-
1
-
-
0032990130
-
Pharmacological properties of trimebutine and N-monodesmethyltrimebutine
-
Roman FJ, Lanet S, Hamon J et al. Pharmacological properties of trimebutine and N-monodesmethyltrimebutine. J Pharmacol Exp Ther 1999;289:1391-7.
-
(1999)
J Pharmacol Exp Ther
, vol.289
, pp. 1391-1397
-
-
Roman, F.J.1
Lanet, S.2
Hamon, J.3
-
2
-
-
0030780325
-
Trimebutine: Mechanism of action, effects on gastrointestinal function and clinical results
-
Delvaux M, Wingate D. Trimebutine: mechanism of action, effects on gastrointestinal function and clinical results. J IntMed Res 1997;25:225-46.
-
(1997)
J IntMed Res
, vol.25
, pp. 225-246
-
-
Delvaux, M.1
Wingate, D.2
-
3
-
-
0018830794
-
A three-part controlled study of trimebutine in the treatment of irritable colon syndrome
-
Luttecke K. A three-part controlled study of trimebutine in the treatment of irritable colon syndrome. Curr Med Res Opin 1980;6:437-43.
-
(1980)
Curr Med Res Opin
, vol.6
, pp. 437-443
-
-
Luttecke, K.1
-
4
-
-
0032457075
-
Gastric ulcer, motility, and trimebutine
-
Tanaka M. Gastric ulcer, motility, and trimebutine. J Gastroenterol 1998;33:916-7.
-
(1998)
J Gastroenterol
, vol.33
, pp. 916-917
-
-
Tanaka, M.1
-
5
-
-
0036215792
-
Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome
-
Kountouras J, Chatzopoulos D, Zavos C, Boura P, Venizelos J, Kalis A. Efficacy of trimebutine therapy in patients with gastroesophageal reflux disease and irritable bowel syndrome. Hepatogastroenterology 2002;49:193-7.
-
(2002)
Hepatogastroenterology
, vol.49
, pp. 193-197
-
-
Kountouras, J.1
Chatzopoulos, D.2
Zavos, C.3
Boura, P.4
Venizelos, J.5
Kalis, A.6
-
6
-
-
77952672104
-
Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome
-
Long Y, Liu Y, Tong J, Qian W, Hou X. Effectiveness of trimebutine maleate on modulating intestinal hypercontractility in a mouse model of postinfectious irritable bowel syndrome. Eur J Pharmacol 2010;636:159-65.
-
(2010)
Eur J Pharmacol
, vol.636
, pp. 159-165
-
-
Long, Y.1
Liu, Y.2
Tong, J.3
Qian, W.4
Hou, X.5
-
7
-
-
3042743867
-
Delayed reaction urticaria due to trimebutine
-
Martin-Garcia C, Martinez-Borque N, Martinez-Bohigas D, Torrecillas-Toro M, Palomeque-Rodriguez MT. Delayed reaction urticaria due to trimebutine. Allergy 2004; 59:789-90.
-
(2004)
Allergy
, vol.59
, pp. 789-790
-
-
Martin-Garcia, C.1
Martinez-Borque, N.2
Martinez-Bohigas, D.3
Torrecillas-Toro, M.4
Palomeque-Rodriguez, M.T.5
-
8
-
-
34547931041
-
Allergic contact dermatitis due to trimebutine
-
Reyes JJ, Farina MC. Allergic contact dermatitis due to trimebutine. Contact Dermatitis 2001;45:164.
-
(2001)
Contact Dermatitis
, vol.45
, pp. 164
-
-
Reyes, J.J.1
Farina, M.C.2
-
9
-
-
0027526251
-
A population based casecohort study of drug-induced anaphylaxis
-
Van der Klauw MM, Stricker BH, Herings RM, Cost WS, Valkenburg HA, Wilson JH. A population based casecohort study of drug-induced anaphylaxis. Br J Clin Pharmacol 1993;35:400-8.
-
(1993)
Br J Clin Pharmacol
, vol.35
, pp. 400-408
-
-
van der Klauw, M.M.1
Stricker, B.H.2
Herings, R.M.3
Cost, W.S.4
Valkenburg, H.A.5
Wilson, J.H.6
-
10
-
-
77953680578
-
Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock)
-
Limsuwan T, Demoly P. Acute symptoms of drug hypersensitivity (urticaria, angioedema, anaphylaxis, anaphylactic shock). Med Clin North Am 2010;94:691-710.
-
(2010)
Med Clin North Am
, vol.94
, pp. 691-710
-
-
Limsuwan, T.1
Demoly, P.2
|